Ftse Mib
33.861,72
0,37%
DAX
17.963,63
0,32%
S&P 500
5.064,20
0,91%
NASDAQ
15.840,96
1,51%
Bitcoin
59.280,97
0,27%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Medicinova Inc (MNOV) Medicinova Inc (MNOV) Notizie

Medicinova Inc

MNOV
1,38
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:09:34
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/4/202401:00GLOBEMediciNova Announces Abstract Regarding Results of a..
27/3/202400:00GLOBEMediciNova Receives a Notice of Allowance for a New Patent..
21/3/202400:00GLOBEMediciNova Announces Two Abstracts regarding MN-001..
12/3/202411:30GLOBEMediciNova Announces New Data and Results of MN-166..
15/2/202422:25EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
19/1/202422:27EDGAR2Form S-8 POS - Securities to be offered to employees in..
19/1/202422:25EDGAR2Form S-8 POS - Securities to be offered to employees in..
19/1/202422:23EDGAR2Form S-8 POS - Securities to be offered to employees in..
19/1/202422:21EDGAR2Form S-8 POS - Securities to be offered to employees in..
17/1/202412:00GLOBEMediciNova Receives a Notice of Grant for a New Patent..
11/1/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202300:00GLOBEMediciNova Announces Abstract Regarding MN-166 (ibudilast)..
07/12/202300:00GLOBEMediciNova Receives a Notice of Decision to Grant for a New..
20/11/202313:42IHMARKETNEWSStocks Set to Open Higher as Investors Await FOMC Minutes..
20/11/202300:00GLOBEMediciNova Announces New Data and Results of a Phase 2..
09/11/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
27/10/202307:00GLOBEMediciNova’s Collaborator Initiates Clinical Development of..
11/10/202301:00GLOBEMediciNova Receives a Notice of Allowance for a New Patent..
05/10/202301:00GLOBEMediciNova Receives Gene Therapy Milestone Payment
28/9/202301:00GLOBEMediciNova Announces Results of Studies under BARDA Contract..
18/8/202301:00GLOBEMediciNova Announces Abstract Regarding MN-166 (ibudilast)..
17/8/202301:00GLOBEMediciNova Receives a Notice of Intention to Grant for a New..
16/8/202301:00GLOBEMediciNova Receives a New Patent Covering MN-001 for the..
15/8/202301:00GLOBEMediciNova Receives a Notice of Intention to Grant for a New..
09/8/202322:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202322:17EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/8/202322:05EDGAR2Form 8-K - Current report
29/6/202312:00GLOBEMediciNova Announces Presentation of Results from the Phase..
15/5/202301:00GLOBEMediciNova Receives a Notice of Intention to Grant for a New..
Apertura: Min: Max:
Chiusura: 1,38

La tua Cronologia

NASDAQ
MNOV
Medicinova
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network